NIH-funded research R01 grant

Cervical cancer outcomes in women with HIV in Zambia and aging biology

Official title: The Impact of Biologic Aging on Immunity-Related Cervical Cancer Outcome Disparities Among Women Living with HIV in Zambia

Funded at University of Tx Md Anderson Can Ctr · NIH-11418470 · Data updated 2026-11-12

A research project is studying how aging processes affect cervical cancer outcomes in women living with HIV in Zambia and what this means for their treatment.

More Aging research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Tx Md Anderson Can Ctr
NIH-funded
Lab location1 site (Houston, United States)
Project startSeptember 19, 2023
Project endAugust 31, 2028
Funding year2026
Award (this year)$663,372
NIH project number5R01CA284623-04
Project IDNIH-11418470 on NIH RePORTER

Who could benefit from this research

Could help

Women living with HIV in Zambia who are diagnosed with cervical cancer and are candidates for chemoradiation therapy.

Less likely to help

Patients without HIV or without cervical cancer are not the target for this work.

What this research studies

The study looks at how biological aging may influence how cervical cancer behaves and responds to chemoradiation in women with HIV, especially in resource-limited settings. Researchers plan to examine epigenetic aging markers and how they relate to cancer progression and treatment toxicity. The goal is to identify age-related factors that could improve care for women with HIV who develop cervical cancer. The work will involve collaboration between U.S. and Zambia-based teams to analyze patient samples and clinical data.

Why it matters

Potential benefit: If successful, findings could lead to tailored treatment considerations for aging PLWH with cervical cancer, potentially improving outcomes and reducing toxicity.

How similar studies have gone: Preliminary data suggest aging and HIV influence cancer biology and treatment response, but direct studies in cervical cancer with HIV are limited.

Where this research is happening

  • University of Tx Md Anderson Can Ctr
    Houston, United States
    Active

Researchers

  • Principal investigator: Lin, Lilie Leming — University of Tx Md Anderson Can Ctr
  • Study coordinator: Lin, Lilie Leming

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.